Featured Publications
Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.
Alexandre Mebazaa, MD, PhD; Markku S. Nieminen, MD, PhD; Milton Packer, MD; Alain Cohen-Solal, MD, PhD; Franz X. Kleber, MD; Stuart J. Pocock, PhD; Roopal Thakkar, MD; Robert J. Padley, MD; Pentti P?der, MD, PhD; Matti Kivikko, MD, PhD; for the SURVIVE Investigators JAMA May 2007 Vol. 297, No. 17 1883-1891
Associations of Gender and Etiology With Outcomes in Heart Failure With Systolic Dysfunction A Pooled Analysis of 5 Randomized Control Trials
Camille G. Frazier MD, Karen P. Alexander MD, L. Kristin Newby MD, MHS, Susan Anderson MS?, Erik Iverson MS?, Milton Packer MD?, Jay Cohn MD?, Sidney Goldstein MD and Pamela S. Douglas MD JACC April 2007 Vol. 49, No. 13 1450-1458
Controlled-release carvedilol: a concluding perspective.
Packer M Am J Cardiology October 2006 Vol. 98, No. 7, Supp.1 67-69
Pharmacokinetic profile of controlled-release carvedilol in patients with left ventricular dysfunction associated with chronic heart failure or after myocardial infarction.
Packer M, Lukas MA, Tenero DM, Baidoo CA, Greenberg BH; 369 Study Group. Am J Cardiology October 2006 Vol. 98, No. 7, Supp. 1 39-45
Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure.
Packer M, Abraham WT, Mehra MR, Yancy CW, Lawless CE, Mitchell JE, Smart FW, Bijou R, O’Connor CM, Massie BM, Pina IL, Greenberg BH, Young JB, Fishbein DP, Hauptman PJ, Bourge RC, Strobeck JE, Murali S, Schocken D, Teerlink JR, Levy WC, Trupp RJ, Silver MA; Prospective Evaluation and Identification of Cardiac Decompensation by ICG Test (PREDICT) Study Investigators and Coordinators. JACC June 2006 Vol. 47, No. 11 2245-2252
